BioSpecifics Technologies Corp. (NASDAQ:BSTC) released its earnings data on Thursday. The company reported $0.25 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.17 by $0.08, Stock Ratings Network.com reports. BioSpecifics Technologies Corp. (NASDAQ:BSTC) shares after opening at $26.69 moved to $27.00 on last trade day and at the end of the day closed at $26.59.Company price to sales ratio in past twelve months was calculated as 12.13 and price to cash ratio as 14.92. BioSpecifics Technologies Corp. (NASDAQ:BSTC) showed a positive weekly performance of 1.80%.
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, reported financial results for the fourth quarter and year ended December 31, 2013.Relypsa Inc (NASDAQ:RLYP) shares advanced 0.66% in last trading session and ended the day on $43.91. RLYP return on equity ratio is recorded as 59.30% and its return on assets is -295.00%.
Equities researchers at Leerink Swann raised their price objective on shares of Enanta Pharmaceuticals (NASDAQ:ENTA) from $29.00 to $45.00 in a research report issued on Monday, Analyst RN reports. Leerink Swann’s price objective would indicate a potential upside of 15.89% from the company’s current price. Enanta Pharmaceuticals Inc (NASDAQ:ENTA) shares moved down -1.47% in last trading session and was closed at $40.25, while trading in range of $39.03-$41.97. Enanta Pharmaceuticals Inc (NASDAQ:ENTA) year to date performance is 47.54%.
IGI Laboratories Inc (NYSEMKT:IG) announced that the U.S. Food and Drug Administration has approved of its new drug, abbreviated as ANDA.The FDA has approved IGI Lab’s application for lidocaine hydrochlioride USP 4% topical solution. This is the first FDA approval for the New Jersey based generic topical pharmaceutical company. It had first submitted ANDA for approval with the FDA in May, 2012. The solution is targeted to produce topical anesthesia of accessible mucous membranes of the nasal and oral cavities and proximal parts of the digestive track.IGI Laboratories, Inc. (NYSEMKT:IG) weekly performance is 13.68%. On last trading day company shares ended up $5.32. IGI Laboratories, Inc. (NYSEMKT:IG) distance from 50-day simple moving average is 42.90%. Analysts mean target price for the company is $5.25.
Leave a Reply